Valneva SE (Austria) Performance
| VLA Stock | EUR 1.88 0.13 6.47% |
The entity has a beta of -0.022, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Valneva SE are expected to decrease at a much lower rate. During the bear market, Valneva SE is likely to outperform the market. At this point, Valneva SE has a negative expected return of -0.8%. Please make sure to validate Valneva SE's potential upside, as well as the relationship between the daily balance of power and market facilitation index , to decide if Valneva SE performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Valneva SE has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders. ...more
| Total Cashflows From Investing Activities | -93.1 M |
Valneva |
Valneva SE Relative Risk vs. Return Landscape
If you would invest 325.00 in Valneva SE on August 29, 2024 and sell it today you would lose (137.00) from holding Valneva SE or give up 42.15% of portfolio value over 90 days. Valneva SE is producing return of less than zero assuming 2.906% volatility of returns over the 90 days investment horizon. Simply put, 25% of all stocks have less volatile historical return distribution than Valneva SE, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Valneva SE Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Valneva SE's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Valneva SE, and traders can use it to determine the average amount a Valneva SE's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.2739
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | VLA |
Estimated Market Risk
| 2.91 actual daily | 25 75% of assets are more volatile |
Expected Return
| -0.8 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.27 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Valneva SE is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Valneva SE by adding Valneva SE to a well-diversified portfolio.
Valneva SE Fundamentals Growth
Valneva Stock prices reflect investors' perceptions of the future prospects and financial health of Valneva SE, and Valneva SE fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Valneva Stock performance.
| Return On Equity | -1.86 | |||
| Return On Asset | -0.18 | |||
| Profit Margin | 0.17 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 1.53 B | |||
| Shares Outstanding | 76.5 M | |||
| Price To Earning | 239.23 X | |||
| Price To Sales | 1.31 X | |||
| Revenue | 438.74 M | |||
| EBITDA | 37.72 M | |||
| Cash And Equivalents | 69.94 M | |||
| Cash Per Share | 1.11 X | |||
| Total Debt | 73.72 M | |||
| Debt To Equity | 55.90 % | |||
| Book Value Per Share | 1.56 X | |||
| Cash Flow From Operations | 76.9 M | |||
| Earnings Per Share | (0.71) X | |||
About Valneva SE Performance
By evaluating Valneva SE's fundamental ratios, stakeholders can gain valuable insights into Valneva SE's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Valneva SE has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Valneva SE has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Valneva SE, a biotech company, engages in developing and commercializing vaccines for infectious diseases with unmet needs. It has operations in Austria, Sweden, the United Kingdom, France, Canada, and the United States. VALNEVA SE is traded on Vienna Stock Exchange in Austria.Things to note about Valneva SE performance evaluation
Checking the ongoing alerts about Valneva SE for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Valneva SE help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Valneva SE generated a negative expected return over the last 90 days | |
| Valneva SE may become a speculative penny stock | |
| The company reported the revenue of 438.74 M. Net Loss for the year was (73.42 M) with loss before overhead, payroll, taxes, and interest of (13.12 M). | |
| About 18.0% of the company outstanding shares are owned by insiders |
- Analyzing Valneva SE's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Valneva SE's stock is overvalued or undervalued compared to its peers.
- Examining Valneva SE's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Valneva SE's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Valneva SE's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Valneva SE's stock. These opinions can provide insight into Valneva SE's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Valneva Stock analysis
When running Valneva SE's price analysis, check to measure Valneva SE's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Valneva SE is operating at the current time. Most of Valneva SE's value examination focuses on studying past and present price action to predict the probability of Valneva SE's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Valneva SE's price. Additionally, you may evaluate how the addition of Valneva SE to your portfolios can decrease your overall portfolio volatility.
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Commodity Directory Find actively traded commodities issued by global exchanges |